If a drug exhibits significant first-pass metabolism following oral administration, which consequence follows, necessitating a higher dose compared to intravenous administration?

💡 Explanation

First-pass metabolism involves drug metabolism in the liver before it reaches systemic circulation, reducing the amount of drug available in the bloodstream. Because of this hepatic processing, lower systemic bioavailability results; therefore, a higher oral dose is needed to achieve the desired therapeutic effect, rather than relying on other routes.

• Why does targeted growth factor receptor therapy sometimes fail to induce apoptosis in cancer cells despite initial success?
• Why does an elderly person in a heatwave risk hyperthermia more than a younger person, even with similar environmental exposure?
• A marathon runner collapses mid-race on a hot day, exhibiting disorientation and cessation of sweating. Why does cessation of sweat contribute to this athlete's hyperthermia?
• Why does pancreatic enzyme activity sharply decrease as chyme enters the jejunum in a patient with untreated celiac disease?
• If a patient presents with fatigue and elevated blood pyruvate despite normal oxygen levels, which vitamin deficiency should be suspected, given its role in the pyruvate dehydrogenase complex?
• A patient with asthma experiences bronchospasms. If a beta-2 adrenergic agonist inhaler is administered, which consequence follows regarding the airway smooth muscle?